Okra Medical

  • sam patrick posted an article
    OKRA Medical product completely destroys highly addictive substances like opioids see more

    Compliments of SC BIZ News

    Okra Medical is pleased to announce The US Patent and Trademark Office issued a Patent for Okra’s SafeMedWaste product suite which provides a safe, environmentally friendly, and cost-effective solution to ending the lifecycle of highly-addictive controlled substances, including opioids.

    “With our patent in hand, we are beyond excited to get SafeMedWaste out onto the market and offer this exciting new alternative to destroying dangerous drugs such as opioids,” said Justin Stas, Chief Technology Officer, Okra Medical.

    Currently many large manufacturers of prescription drugs incinerate their waste which is a costly solution to meet the regulatory requirement for destruction. Citizens, who have leftover prescription drugs often have to wait months for special “take-back” programs to safely discard the controlled substances. Now, Okra Medical’s SafeMedWaste provides a disposal product with verified results from a DEA-licensed laboratory proving its effectiveness for regulatory destruction of more than 30 controlled substances.

    SafeMedWaste is the only drug disposal product verified to completely denature a wide variety of controlled substances using high performance liquid chromatography, mass spectroscopy(HPLC-MS). HPLC-MS is the only data that the DEA considers reliable and resolute enough to meet their definition of non retrievable based on what we know currently.

    “Receiving this patent has taken more than a year of hard work, but it’s worth every minute knowing SafeMedWaste will help people destroy highly addictive drugs and potentially keep them out of the hands of people who might misuse them,” said Okra Medical’s CEO Marshall Hartmann.

    According to statistics from a National Survey on Drug Use and Health, 11.4 million Americans misused illegal prescription opioids in 2017. SafeMedWaste provides a critical solution through its breakthrough formula that completely destroys highly addictive controlled substances often used in hospitals, hospice, pharmacies and veterinary care clinics. Destroying unused and unwanted prescription drugs helps eliminate the threat of diversion and misuse.

    Patents are only granted for new, useful and non-obvious inventions. Okra Medical also filed a Patent Cooperation Treaty (PCT) application to protect SafeMedWaste intellectual property internationally.

    About Okra Medical Inc.

    Okra Medical, Inc., headquartered in Johns Island, South Carolina, specializes in product development, manufacturing and strategic sourcing of controlled pharmaceutical substance disposal solutions. Founded in 2018, the Company’s mission is to improve public health. Its best-in-class suite of SafeMedWaste products use single formulas that are fully compliant with DEA regulations requiring non-retrievable destruction of controlled substances. Okra Medical is a strategic sourcing partner to hospitals, hospice facilities, law enforcement agencies, pharmaceutical manufacturers, and veterinary care clinics. Visit www.okramedical.com

  • sam patrick posted an article
    Okra Medical donates face masks to 8 hospitals see more

    Okra Medical, a life sciences start-up company based on Johns Island, South Carolina, donated nearly 100,000 healthcare face masks to eight hospitals and one pediatric group serving on the frontlines of the COVID-19 pandemic. The majority of the masks are smaller in size to benefit children and young adults.

    “Like many in America, the coronavirus brought our business to a standstill,” said Marshall Hartmann, CEO, Okra Medical. “We redirected our laboratory efforts to securing medical supplies to both help fund our payroll and to give back to our community.”

    Okra Medical had planned to launch the company’s new pharmaceutical drug destroyer, SafeMedWaste in mid-March. Then COVID-19 hit. The leadership team started looking for ways to leverage their international relationships to support the company and the community. They landed on securing PPE for the healthcare industry.

    “We are overwhelmed with gratitude for the waves of donations received from the Charleston community. Most donors have said that they don’t need or want any thanks, they just want to help in any way they can, and assisting them by providing an avenue to receive has been an honor. As we try to stay focused and rise to the strategic challenges we’re all being faced with, the impact these donations are having, on both a personal and national level, is incredible.” Jennifer Simon, MUSC.

    MUSC is one of eight hospitals benefiting from Okra Medical’s donations. The full list is:

    • Medical University of South Carolina, Charleston, SC
    • Roper St. Francis Healthcare, Charleston, SC
    • Coastal Pediatric Associates, North Charleston, SC
    • Prisma Health, Greenville, SC
    • Shriners Hospital for Children, Greenville, SC
    • Conway Medical Center, Conway, SC
    • WakeMed Children’s Hospital, Raleigh, NC
    • Cincinnati Children's Hospital Medical Center, Cincinnati, OH
    • University of Pittsburgh Medical Center Children’s Hospital, Pittsburg, PA

    “We are thankful for the health care heroes willing to serve at a time like this,” said Hartmann. “Giving back is the easy part. U.S. Senator Tim Scott’s Office and SCBIO made donating even easier by providing helpful guidance to match donors with organizations in need.”

    “The rapid response of Senator Tim Scott’s team allowed us to quickly get donation masks into the hands of people who needed them most,” said Justin Stas, Chief Technical Officer, Okra Medical. “We are very proud of the way our South Carolina community, from government to individuals, has come together during this difficult time.”

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has more than 675 firms, including Okra Medical, directly involved and 43,000 professionals employed directly or indirectly in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.

    “We continue to be humbled by the amazing and impactful response to this public health crisis by SCBIO stakeholders like Okra Medical. Their gracious donation of thousands of critically important pediatric healthcare face masks to help ensure the safety of children in hospital environments during this global pandemic is a great example of Okra’s culture of servant leadership combined with their business expertise and innovativeness. We’re very proud and grateful that they are a highly engaged member of our organization,” said Sam Konduros, President/CEO of SCBIO.

    A member of SCBIO, Okra Medical has developed and validated a patented product called SafeMedWaste that will simplify the way pharmaceutical manufacturers, hospitals, and individuals destroy and dispose of highly-addictive controlled substances like opioids. To learn more about the environmentally-friendly product, watch this video on the company website.

    About Okra Medical Inc.
    Okra Medical, Inc., headquartered in Johns Island, South Carolina, specializes in product development, manufacturing and strategic sourcing of controlled pharmaceutical substance disposal solutions. Founded in 2018, the Company’s mission is to improve public health. Its best-in-class suite of SafeMedWaste products use single formulas that are fully compliant with DEA regulations requiring non-retrievable destruction of controlled substances. Okra Medical is a strategic sourcing partner to hospitals, hospice facilities, law enforcement agencies, pharmaceutical manufacturers, and veterinary care clinics. Visit www.okramedical.com.